Follow The Filings

PACS PACS Group

PACS Group earnings company data as of 4:49 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 18 Nov EPS 0.56 — —
Rev — — —

Insider trades

Open-market buys and sales by PACS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PACS insider trades
  • $500K bought by 1 insider
  • $6.2M sold by 3 insiders outside a trading plan
  • $88.3M sold by 5 insiders under 10b5-1 plans
  1. Jason Hulse Murray CEO
    Planned sale
    $2.2M 45,707 shares at $47.64 0.1% of stake
    Traded Oct 19–21 Filed Oct 21
  2. Jason Hulse Murray CEO
    Planned sale
    $5.6M 118,729 shares at $47.29 0.2% of stake
    Traded Oct 14–16 Filed Oct 16
  3. Joshua Jergensen COO
    Planned sale
    $1.8M 40,000 shares at $44.50 1.6% of stake
    Traded Oct 14 Filed Oct 16
  4. Jason Hulse Murray CEO
    Planned sale
    $1.6M 36,692 shares at $43.08 0.1% of stake
    Traded Oct 6–7 Filed Oct 7
  5. Jason Hulse Murray CEO
    Planned sale
    $3.5M 83,308 shares at $42.00 0.2% of stake
    Traded Oct 1–5 Filed Oct 5
  6. Joshua Jergensen COO
    Planned sale
    $1.7M 40,000 shares at $43.13 1.6% of stake
    Traded Sep 16 Filed Sep 17
  7. Mark Hancock Director
    Planned sale
    $13M 300,000 shares at $43.48 0.6% of stake
    Traded Sep 14–15 Filed Sep 15
  8. Jason Hulse Murray CEO
    Planned sale
    $887K 19,617 shares at $45.19 <0.1% of stake
    Traded Sep 10–14 Filed Sep 14
  9. Jason Hulse Murray CEO
    Planned sale
    $2.2M 51,887 shares at $43.12 0.1% of stake
    Traded Sep 4–9 Filed Sep 9
  10. Jason Hulse Murray CEO
    Planned sale
    $2.9M 68,113 shares at $42.63 0.1% of stake
    Traded Sep 1–3 Filed Sep 3
  11. Patrick Hugh Conway Director
    Sale
    $155K 3,497 shares at $44.41 28% of stake
    Traded Aug 14 Filed Aug 27
  12. Jason Hulse Murray CEO
    Planned sale
    $6.6M 150,550 shares at $43.92 0.3% of stake
    Traded Aug 20–21 Filed Aug 24
  13. Jason Hulse Murray CEO
    Planned sale
    $10.4M 236,116 shares at $44.20 0.4% of stake
    Traded Aug 17–19 Filed Aug 19
  14. Joshua Jergensen COO
    Planned sale
    $1.8M 40,000 shares at $45.59 1.6% of stake
    Traded Aug 12 Filed Aug 14
  15. Mark Hancock Director
    Planned sale
    $614K 13,628 shares at $45.04 <0.1% of stake
    Traded Jul 14–15 Filed Jul 16

Also filed in the last 12 months, not counted as buying or selling: 33 stock grants, 8 share withholdings for taxes, and 2 gifts.

SEC filings

Recent issuer filings from EDGAR, 6 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 5.07
8-K 2.02,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.